WELEDA sirop contre la toux fl 100 ml

7680653420016 CH-65342 R05CA10 20.02.
WELEDA sirop contre la toux fl 100 ml
WELEDA sirop contre la toux fl 100 ml
WELEDA sirop contre la toux fl 100 ml
1 / 3
google

Details

Product number
6534201
CPT
-
Packaging group
100
Unit
ml
Composition
decoctum aquosum 990 mg ex thymi herba (Thymus vulgaris L./Thymus zygis L., herba), anisi fructus (Pimpinella anisum L., fructus), marrubii vulgaris herba (Marrubium vulgare L., herba), serpylli herba (Thymus serpyllum L., herba) et dulcamarae stipites (Solanum dulcamara L., stipites) (19: 3.3: 2.3: 2.3: 1), DER: 1:6-7, Auszugsmittel aqua purificata, althaeae radicis extractum aquosum fluidum (Althaea officinalis L., radix) 165 mg, DER: 1:4-8, Auszugsmittel aqua purificata, psychotria ipecacuanha, ethanol. decoctum (HAB) TM 3.3 mg, drosera (HAB) D2 3.3 mg, pulsatilla vulgaris (HAB) D3 0.4 mg, saccharum 1973 mg, malti extractum, aqua purificata, ad solutionem pro 2.5 ml.

Articles (1)

Weleda Hustensirup, Sirup
Sirup
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/04/2024
Patient information leaflet
Français
04/04/2024
Patient information leaflet
Italien
04/04/2024

Detailed composition

Substance Quantity Type Category
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
165.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
3.3 MG Substance Wirkstoff (Principe actif)
(N/A)
3.3 MG Substance Wirkstoff (Principe actif)
(N/A)
0.4 MG Substance Wirkstoff (Principe actif)
(N/A)
1973.0 MG Substance HBESI
(N/A)
- Substance HIMDK
(N/A)
- Substance HNIDK

Authorization holder

Weleda AG

4144 Arlesheim

Authorization information

Swissmedic authorization number
65342
Drug name
Weleda Hustensirup, Sirup
Galenic form
SIRU
Authorization status
Z
Dispensation category
D
First authorization
05/08/2015
Authorization expiration date
31/12/9999
IT number
20.02.
Domain
Human medicine
Field of application
Gemäss der anthroposophischen Menschen- und Naturkenntnis bei akuten Erkrankungen der Atemwege zur Förderung des Abhustens von zähem Schleim (Expektoration) und zur Linderung des Hustenreizes

Packaging details

Description (FR)
WELEDA sirop contre la toux fl 100 ml
Description (DE)
WELEDA Hustensirup Fl 100 ml
Market launch
05/08/2015
Narcotic (BTM)
No